tiprankstipranks
Bio-Rad sees FY24 revenue up 1%-2.5%
The Fly

Bio-Rad sees FY24 revenue up 1%-2.5%

Implies $2.70B-$2.74B, consensus $2.71B. Sees operating margin of approximately 13.5% to 14.0% vs. 14.2% in FY23.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on BIO:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles